ArticlePloS one2019

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.

Monika Hebeisen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.